Anger, a Result and Cause of Stroke: A Narrative Review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Post-stroke mood and emotional disturbances are frequent and diverse in their manifestations. Among them, post-stroke depression is the best known. Although post-stroke anger (PSA) has been studied relatively less, it can be as frequent as depression. Manifestations of PSA range from overt aggressive behaviors (including hitting or hurting others) to becoming irritable, impulsive, hostile, and less tolerable to family members. The possible pathophysiological mechanisms of PSA include neurochemical dysfunction due to brain injury, frustration associated with neurological deficits or unfavorable environments, and genetic predisposition. PSA causes distress in both patients and their caregivers, negatively influences the patient’s quality of life, and increases the burden on caregivers. It can be treated or prevented using various methods, including pharmacological therapies. In addition, anger or hostility may also be a risk or triggering factor for stroke. The hazardous effects of anger may be mediated by other risk factors, including hypertension or diabetes mellitus. The identification of anger as a result or cause of stroke is important because strategic management of anger may help improve the patient’s quality of life or prevent stroke occurrence. In this narrative review, we describe the phenomenology, prevalence, factors or predictors, relevant lesion locations, and pharmacological treatment of PSA. We further describe the current evidence on anger as a risk or triggering factor for stroke.
Abstract
Post-stroke mood and emotional disturbances are frequent and diverse in their manifestations. Among them, post-stroke depression is the best known. Although post-stroke anger (PSA) has been studied relatively less, it can be as frequent as depression. Manifestations of PSA range from overt aggressive behaviors (including hitting or hurting others) to becoming irritable, impulsive, hostile, and less tolerable to family members. The possible pathophysiological mechanisms of PSA include neurochemical dysfunction due to brain injury, frustration associated with neurological deficits or unfavorable environments, and genetic predisposition. PSA causes distress in both patients and their caregivers, negatively influences the patient’s quality of life, and increases the burden on caregivers. It can be treated or prevented using various methods, including pharmacological therapies. In addition, anger or hostility may also be a risk or triggering factor for stroke. The hazardous effects of anger may be mediated by other risk factors, including hypertension or diabetes mellitus. The identification of anger as a result or cause of stroke is important because strategic management of anger may help improve the patient’s quality of life or prevent stroke occurrence. In this narrative review, we describe the phenomenology, prevalence, factors or predictors, relevant lesion locations, and pharmacological treatment of PSA. We further describe the current evidence on anger as a risk or triggering factor for stroke.
참고문헌 (49)
- Jong S. Kim, "Post-stroke Mood and Emotional Disturbances: Pharmacological Therapy Based on Mechanisms", 대한뇌졸중영문학회지, 18(3), pp.244~255 (2016), 대한뇌졸중학회
- Lau CG, "Poststroke agitation and aggression and social quality of life : a case control study", Top Stroke Rehabil, 24, pp.126~133 (2017)
- Noh SM, "Emotional disturbance in CADASIL : its impact on quality of life and caregiver burden", Cerebrovasc Dis, 37, pp.188~194 (2014)
- Kowalska K, "Delirium post-stroke: short- and long-term effect on depression, anxiety, apathy and aggression (research study-part of PROPOLIS Study)", J Clin Med, 9, pp.2232~ (2020)
- Gainotti G, "Emotional behavior and hemispheric side of the lesion", Cortex, 8, pp.41~55 (1972)
- Carota A, "Catastrophic reaction in acute stroke : a reflex behavior in aphasic patients", Neurology, 57, pp.1902~1905 (2001)
- Kim JS, "Inability to control anger or aggression after stroke", Neurology, 58, pp.1106~1108 (2002)
- Choi-Kwon S, "Fluoxetine treatment in poststroke depression, emotional incontinence, and anger proneness: a double-blind, placebo-controlled study", Stroke, 37, pp.156~161 (2006)
- Choi-Kwon S, "Factors associated with post-stroke anger proneness in ischaemic stroke patients", Eur J Neurol, 20, pp.1305~1310 (2013)
- Chan KL, "Aggressive behavior in patients with stroke : association with psychopathology and results of antidepressant treatment on aggression", Arch Phys Med Rehabil, 87, pp.793~798 (2006)
- Santos CO, "Anger, hostility and aggression in the first days of acute stroke", Eur J Neurol, 13, pp.351~358 (2006)
- Starkstein SE, "Catastrophic reaction after cerebrovascular lesions: frequency, correlates, and validation of a scale", J Neuropsychiatry Clin Neurosci, 5, pp.189~194 (1993)
- Montgomery SA, "A new depression scale designed to be sensitive to change", Br J Psychiatry, 134, pp.382~389 (1979)
- Asberg M, "A comprehensive psychopathological rating scale", Acta Psychiatr Scand Suppl, 271, pp.5~27 (1978)
- Annoni JM, "Emotional disturbances after stroke", Clin Exp Hypertens, 28, pp.243~249 (2006)
- Huang HC, "The mediating effect of psychological distress on functional dependence in stroke patients", J Clin Nurs, 23, pp.3533~3543 (2014)
- Boseong Kwon, "Long-Term Changes in Post-Stroke Depression, Emotional Incontinence, and Anger", 대한뇌졸중영문학회지, 23(2), pp.263~272 (2021), 대한뇌졸중학회[DOI]
- Garcia-Rudolph A, "Stroke survivors on Twitter : sentiment and topic analysis from a gender perspective", J Med Internet Res, 21, pp.e14077~ (2019)
- Paradiso S, "Self-reported aggressive behavior in patients with stroke", J Nerv Ment Dis, 184, pp.746~753 (1996)
- Tang WK, "Location of acute infarcts and agitation and aggression in stroke", J Neuropsychiatry Clin Neurosci, 29, pp.172~178 (2017)
- Toscano M, "Serotonergic correlation with anger and aggressive behavior in acute stroke patients: an intensity dependence of auditory evoked potentials (IDAP) study", Eur Neurol, 72, pp.186~192 (2014)
- Gupta M, "Behavioural and psychological symptoms in poststroke vascular cognitive impairment", Behav Neurol, 2014, pp.430128~ (2014)
- Ko M, "Poststroke emotional disturbances and a tryptophan hydroxylase 2 gene polymorphism", Brain Behav, 8, pp.e00892~ (2018)
- Manuck SB, "A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity", Psychiatry Res, 95, pp.9~23 (2000)
- Everson SA, "Anger expression and incident stroke : prospective evidence from the Kuopio ischemic heart disease study", Stroke, 30, pp.523~528 (1999)
- Williams JE, "The association between trait anger and incident stroke risk: the Atherosclerosis Risk in Communities (ARIC) Study", Stroke, 33, pp.13~19 (2002)
- Rosa PB, "Anger and stroke : a potential association that deserves serious consideration", Acta Neuropsychiatr, 28, pp.346~351 (2016)
- Choi-Kwon S, "Comparing perceived burden for Korean and American informal caregivers of stroke survivors", Rehabil Nurs, 34, pp.141~150 (2009)
- Williams LS, "Development of a stroke-specific quality of life scale", Stroke, 30, pp.1362~1369 (1999)
- Scholteop Reimer WJ, "Assessment of burden in partners of stroke patients with the sense of competence questionnaire", Stroke, 29, pp.373~379 (1998)
- Coccaro EF, "Fluoxetine and impulsive aggressive behavior in personality-disordered subjects", Arch Gen Psychiatry, 54, pp.1081~1088 (1997)
- Pollock BG, "A double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia", Am J Geriatr Psychiatry, 15, pp.942~952 (2007)
- Kim JS, "Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study", Lancet Psychiatry, 4, pp.33~41 (2017)
- Choi-Kwon S, "Fluoxetine improves the quality of life in patients with poststroke emotional disturbances", Cerebrovasc Dis, 26, pp.266~271 (2008)
- Fleminger S, "Pharmacological management for agitation and aggression in people with acquired brain injury", Cochrane Database Syst Rev, 1, pp.CD003299~ (2003)
- Glenn MB, "Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients", Am J Phys Med Rehabil, 68, pp.221~226 (1989)
- Ferro JM, "Neuropsychiatric sequelae of stroke", Nat Rev Neurol, 12, pp.269~280 (2016)
- Ferro JM, "Emotions after stroke : a narrative update", Int J Stroke, 15, pp.256~267 (2020)
- McCloskey MS, "Unhealthy aggression : intermittent explosive disorder and adverse physical health outcomes", Health Psychol, 29, pp.324~332 (2010)
- Eng PM, "Anger expression and risk of stroke and coronary heart disease among male health professionals", Psychosom Med, 65, pp.100~110 (2003)
- Chen H, "Anger, hostility and risk of stroke: a meta-analysis of cohort studies", J Neurol, 266, pp.1016~1026 (2019)
- Tezuka K, "Anger expression and the risk of cardiovascular disease among urban and rural Japanese residents : the Circulatory Risk in Communities Study", Psychosom Med, 82, pp.215~223 (2020)
- Sharma A, "Prevalence of triggering factors in acute stroke : hospital-based observational cross-sectional study", J Stroke Cerebrovasc Dis, 24, pp.337~347 (2015)
- Koton S, "Triggering risk factors for ischemic stroke : a case-crossover study", Neurology, 63, pp.2006~2010 (2004)
- Smyth A, "Anger or emotional upset and heavy physical exertion as triggers of stroke : the INTERSTROKE study", Eur Heart J, 43, pp.202~209 (2022)
- Ohira T, "Psychological distress and cardiovascular disease:the Circulatory Risk in Communities Study (CIRCS)", J Epidemiol, 20, pp.185~191 (2010)
- Moons WG, "Anger and fear responses to stress have different biological profiles", Brain Behav Immun, 24, pp.215~219 (2010)
- Girard D, "Trait hostility and acute inflammatory responses to stress in the laboratory", PLoS One, 11, pp.e0156329~ (2016)
- Tezuka K, "Impact of perceived social support on the association between anger expression and the risk of stroke:the Circulatory Risk in Communities Study (CIRCS)", J Epidemiol (2021)[DOI]